Psychedelic Compound from Magic Mushrooms Produced in Yeast
Scientists from DTU Biosustain prove that psilocybin, a potential drug for treating depression and other psychological conditions, can be produced in yeast
psychiatric disorders
Scientists Create Tool to Detect Genes Associated with Psychiatric, Brain Diseases
Researchers created H-MAGMA, a computational tool that improves current technology used to link non-coding genetic variants to the genes associated with diseases through genome-wide association
Evolutionary Changes in the Human Brain May Have Led to Bipolar Disorder and Schizophrenia
A study identifies an unusually lengthy array of tandem repeats found only within the human version of a gene governing calcium transport in the brain
Psychedelic Drugs Promote Neural Plasticity in Rats and Flies
Psychedelic drugs may have mind-altering powers in the physical sense, too
Cannabis Linked to Bipolar Symptoms in Young Adults
Adolescent cannabis use is an independent risk factor for future hypomania—often experienced as part of bipolar disorder—finds new research led by University of Warwick
Key Psychiatric Drug Target Comes Into Focus
UC San Francisco / UNC Chapel Hill team determines first high-resolution structure of dopamine receptor
B Vitamins Reduce Schizophrenia Symptoms, Study Finds
"This could be an important advance, given that new treatments for this condition are so desperately needed," lead author says
Researchers Find Novel Chemical Switch That May Help Decrease Crucial Symptoms of Schizophrenia
Research in mice could have implications for human brain disease
Researchers Describe a Novel Underlying Mechanism Involved in PTSD and Other Anxiety Disorders
Studies fill an important gap in knowledge between the molecular, circuit and behavioral effects of the brain-signaling molecule called neuropeptide Y
Alcohol Prevents Ability to Extinguish Fearful Memories in Mice
Insight into cellular mechanisms illuminates biological target for PTSD therapy